DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Boniva (Ibandronate Sodium) - Current Clinical Trials

 
 



Boniva Related Clinical Trials

Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition [Completed]

PTH & Ibandronate Combination Study (PICS) [Completed]

A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. [Completed]

BONVIVA(Ibandronate) PMS(Post-marketing Surveillance ) [Completed]

Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis [Recruiting]

BONVIVA(Ibandronate) Injection PMS(Post-marketing Surveillance) [Completed]

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis [Completed]

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients [Active, not recruiting]

A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo [Completed]

Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus [Completed]

Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) [Completed]

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone [Withdrawn]

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. [Completed]

Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate [Completed]

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort [Suspended]

Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis [Terminated]

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis [Completed]

Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids [Completed]

Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis [Completed]

A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates [Completed]

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis [Completed]

SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. [Completed]

Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation. [Active, not recruiting]

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) [Completed]

A Study of Adherence to Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP). [Completed]

Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled Trial [Recruiting]

A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis [Completed]

The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density [Terminated]

BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis. [Completed]

The Effect Of Oral Ibandronate In Male Osteoporosis [Completed]

MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis [Completed]

Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers [Enrolling by invitation]

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva [Completed]

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment [Completed]

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis [Completed]

A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease. [Completed]

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer [Active, not recruiting]

Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis [Recruiting]

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia [Completed]

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. [Completed]

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. [Completed]

A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. [Completed]

ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. [Completed]

Study of Investigational Drug in Osteoporosis (MK-0217-908) [Completed]

Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain [Completed]

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease. [Completed]

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. [Terminated]

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease [Terminated]

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain [Terminated]

Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients [Recruiting]

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) [Completed]

Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis [Completed]

S0307 Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]

A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate [Completed]

Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation [Completed]

A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) [Completed]

Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis [Enrolling by invitation]

Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use [Recruiting]

Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers [Enrolling by invitation]

Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment [Recruiting]

Bisphosphonate-coated Dental Implants [Completed]

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 [Withdrawn]

Safety Assessment Among Women With Postmenopausal Osteoporosis and Men With Osteoporosis in Multiple Observational Databases [Recruiting]

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy [Recruiting]

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017